LncRNA PITPNA-AS1 as a Potential Diagnostic Marker and Therapeutic Target Promotes Hepatocellular Carcinoma Progression via Modulating miR-448/ROCK1 Axis
Authors:
Open Access
- 12 May 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 8
Abstract
Background: Long non-coding RNAs are critical to hepatocellular carcinoma (HCC) developments. LncRNA PITPNA antisense RNA 1 (PITPNA-AS1) is a new regulator in several tumors. However, the mechanism by which PITPNA-AS1 mediates the tumorigenesis of HCC remains unclear.Methods: RT-qPCR was used to detect the level of PITPNA-AS1 in HCC specimens and cells. The biological functions of PITPNA-AS1 were explored by several functional experiments in vivo and in vitro. The binding relationship among PITPNA-AS1, miR-448 and ROCK1 were studied by Luciferase assay and pull-down assays.Results: We found that PITPNA-AS1 expressions were distinctly upregulated in both HCC specimens and cell lines. High PITPNA-AS1 levels were an unfavorable biomarker for patients with HCC. Functionally, knockdown of PITPNA-AS1 suppressed the proliferation, migration and invasion of HCC cells. Mechanistically, PITPNA-AS1 functioned as competing endogenous RNA to increase ROCK1 expressions via sponging miR-448.Conclusion: The newly identified PITPNA-AS/miR-448/ROCK1 axis promoted the oncogenicity of HCC cells. This novel axis is likely to be a promising HCC therapeutic aim.Keywords
This publication has 30 references indexed in Scilit:
- Long Noncoding RNA and Cancer: A New ParadigmCancer Research, 2017
- LncRNA-mediated regulation of cell signaling in cancerOncogene, 2017
- Hepatocellular carcinoma: diagnosis and proposal of treatment.2016
- RhoE/ROCK2 regulates chemoresistance through NF-κB/IL-6/ STAT3 signaling in hepatocellular carcinomaOncotarget, 2016
- Endogenous microRNA sponges: evidence and controversyNature Reviews Genetics, 2016
- RhoA/Rho-Kinase in the Cardiovascular SystemCirculation Research, 2016
- MiR-506 suppresses cell proliferation and tumor growth by targeting Rho-associated protein kinase 1 in hepatocellular carcinomaBiochemical and Biophysical Research Communications, 2015
- ceRNA in cancer: possible functions and clinical implicationsJournal of Medical Genetics, 2015
- The Landscape of long noncoding RNA classificationTrends in Genetics, 2015
- Hepatocellular Carcinoma: Overcoming Challenges in Disease ManagementClinical Gastroenterology and Hepatology, 2006